Senior insider sale
EVP and CFO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$1.09M
2.52K shares
What this filing means
DIER MARDI plans to sell 2.52K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $1.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001950047-26-002326
Officer· EVP and CFO
Since Mar 2026
2.52K
Shares to sell
$1.09M
Approx. market value
1.34K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/1/2026
1.34KTotal acquired1.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Restricted Stock Units N/A | 1.34K | — |
| Total | 1.34K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.18K
Market value
$505.4K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.34K
Market value
$587.0K
3/6/2026
Total
Units
2.52K
Value
$1.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 1.18K | $505.4K | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 1.34K | $587.0K | NASDAQ | Planned |
| Total | 2.52K | $1.09M | ||